Indoco Remedies Ltd.

Milestones


  • Indoco receives UKMHRA approval for solid dosages Plant I in Goa

  • Indoco receives the IDMA Best Patent Award for four API Process Patents

  • Indoco receives patent grant for Linezolid & Brinzolamide (FDFs) from United States Patent and Trademark Office (USPTO)


  • Indoco Honoured with the IDMA Best Patent Award for Three International Patents

  • Indoco achieves a milestone of Rs.1000 Crs

  • Indoco acquires Oral Solid Dosage manufacturing facility in Baddi from Micro Labs Ltd., Bangalore

  • Indoco's Allopurinol ANDA gets USFDA approval

  • Indoco climbs 187 ranks up - Fortune India

  • Indoco receives USFDA approval for solid dosages Plant I in Goa

  • Indoco honoured with the 'Best Patent Award' by PHARMEXCIL in the Bulk Drugs / API category


  • Indoco wins IDMA Patent Appreciation Award for Betaxolol


  • US-FDA approves Sterile (Plant II) and Solid Dosages (Plant III) facilities in Goa

  • IDMA Best Patent Award for Tazarotene & Adapalene


  • Indoco announced the signing of an agreement with DSM, a € 9 billion Company, for commercial cooperation for Active Pharmaceutical Ingredients (APIs). Indoco and DSM have formed a strategic alliance, wherein DSM shall be marketing and selling the APIs manufactured by INDOCO

  • Innovation in Quality Award at CPhI Pharma Awards


  • Indoco received the Silver Quality Excellence Award for Sterile Manufacturing Facility in Goa and Solid Dosages Facility in Baddi (Himachal\Pradesh) at IDMA's Golden Jubilee celebrations


  • Indoco Remedies teams up with ASPEN, South Africa by licensing out intellectual property (dossiers) for marketing its products in emerging markets covering 30 countries, including SA, Brazil, Mexico, Venezuela, Russia & Australia

  • Indoco Remedies licenses out technology to Watson Pharmaceuticals Inc. USA. Under the terms of profit sharing agreement, Indoco will develop, manufacture and supply a basket of sterile products to Watson for the US market


  • UK-MHRA approval for the Solid Oral Dosage forms at Baddi Plant

  • Export sales exceeded Rs. 1 Billion in the FY 08-09

  • Successfully faced Slovenia audit for the Sterile Facility at Goa Plant II for the Injections Area



  • IDMA Quality Excellence Awards 2008 - The Sterile Facility at Goa Plant II received the Gold Award and the Solid Dosage Forms and Externals Facility at Goa Plant I received the Silver Award

  • TGA (Australia) approval for the Solid Dosage, Liquid Orals and Creams &Ointments Dosage forms at GOA Plant I

  • First shipment of Diclofenac Ophthalmic solution shipped to USA against an approved ANDA

  • Successfully faced Slovenia audit for the Solid Oral Dosage forms at Baddi Plant

  • MCC (South Africa) approval for the Solid Dosage facility at GOA Plant I and for the Sterile facility at Goa Plant II


  • ANVISA (Brazil) approval for the Solid Dosage facility at GOA Plant I

  • Commencement of exports to the US markets

  • Launch of Warren-Excel and Spera - two specialty marketing divisions


  • US-FDA approval for Ophthalmic facility, Plant-II in GOA

  • Contract signed for supply of 18 generic products to German Market

  • 2 ANDAs filed with USFDA

  • Commencement of liquid manufacturing facility at Baddi, Himachal Pradesh

  • New R&D Centre at Rabale, near Mumbai becomes functional

  • Solid Dosage facility at Goa Plant I re-inspected & approved by UK-MHRA

  • UK-MHRA approval for Creams & Ointments facility

  • Darmstadt-Germany approves our Goa facility for Solid Dosage manufacturing

  • Acquisition of LaNOVA Chem Pvt. Ltd. with its brand new API manufacturing facility of international standards

  • Launch of Surge - a specialty marketing division


  • First ANDA filed on the basis of Exhibit batches manufactured in our sterile facility in Goa

  • Development Contracts for injectable products signed with a US Company

  • Tablet capacity doubled by commissioning an extended facility in the existing UK-MHRA approved plant

  • Shares of the Company listed on BSE and NSE


  • First Contract for Development services with US Company

  • Karvol brand acquisition from Solvay Pharmaceuticals Pvt. Ltd

  • Four Patent applications filed

  • Company jumps five ranks in two yrs in the ORG-IMS Retail Audit


  • UK-MHRA approval for the Solid Dosage facility at Plant I

  • Exports to regulated markets commence

  • First contract for Dossier Development with European company

  • Domestic Marketing makes a foray into the lifestyle segment


  • State-of-the-art sterile facility, Plant II commissioned at Verna Goa


  • New Corporate Office at Indoco House

  • Acquisition of Warren, Company makes presence in Ophthalmic & Dental Segments


  • Commencement of production in Goa Plant I


  • R&D recognized by DSIR